KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oaktree Specialty Lending (OCSL) Cash & Equivalents (2021 - 2026)

Oaktree Specialty Lending's Cash & Equivalents history spans 5 years, with the latest figure at $80.8 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 28.43% to $80.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $80.8 million, a 28.43% decrease, with the full-year FY2025 number at $79.6 million, up 24.49% from a year prior.
  • Cash & Equivalents hit $80.8 million in Q4 2025 for Oaktree Specialty Lending, up from $79.6 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for OCSL hit a ceiling of $136.4 million in Q3 2023 and a floor of $17.4 million in Q4 2022.
  • Historically, Cash & Equivalents has averaged $77.3 million across 5 years, with a median of $79.8 million in 2025.
  • Biggest five-year swings in Cash & Equivalents: surged 546.47% in 2023 and later tumbled 53.12% in 2024.
  • Tracing OCSL's Cash & Equivalents over 5 years: stood at $29.3 million in 2021, then tumbled by 40.74% to $17.4 million in 2022, then surged by 546.47% to $112.4 million in 2023, then grew by 0.48% to $112.9 million in 2024, then dropped by 28.43% to $80.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for OCSL at $80.8 million in Q4 2025, $79.6 million in Q3 2025, and $79.8 million in Q2 2025.